<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260223068925N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-07-01</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The effect of core stability training following hip arthroplasty on balance, physical function, and quality of life in patients with unilateral development dysplasia of the hip.</public_title>
      <acronym></acronym>
      <scientific_title>The effect of core stability training following hip arthroplasty on balance, physical function, and quality of life in patients with unilateral development dysplasia of the hip.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-27</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/89245</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Few studies have examined the effects of core stability strengthening exercises after total hip arthroplasty, particularly in individuals with developmental hip dislocation. In this study, we aim to investigate the effects of core stability strengthening exercises on balance, functional ability, and quality of life in individuals with developmental hip dislocation following total hip replacement surgery, Randomization description: Randomization will be performed using Random Allocation Software. In the software settings, the number of groups will be set to two (Group A: intervention group; Group B: control group), with a 1:1 allocation ratio. A block size of 4 and a total sample size of 40 participants will be specified. The software will then generate a random allocation sequence.

Whenever an eligible participant is enrolled in the study, they will be assigned to the next available allocation in the randomization sequence and allocated to either Group A or Group B. The assigned group (A or B) will be written on a sealed envelope and provided for implementation of the intervention. Participants will remain unaware of their group assignment, whereas the treating physiotherapist will know the allocation in order to deliver the appropriate intervention, Blinding description: The assessor will be blinded to the group allocation of the participants. The participants will also be unaware of whether they are assigned to the treatment group or the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>"Physiotherapy after Hip Joint Replacement in Individuals with Congenital Hip Dislocation".</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The patient will attend the physiotherapy center 24 hours after surgery and will continue treatment for 6 weeks. During this period, the patient will attend the physiotherapy center three times per week. The treatment program will include 15 minutes of Transcutaneous Electrical Nerve Stimulation (TENS), 15 minutes of Interferential Therapy (IFT), hip strengthening exercises, range of motion exercises, gait training, and functional exercises (2 sets of 10 repetitions). If the patient develops lower-limb muscle spasms, dry needling or the Graston technique will be used as appropriate.Six weeks after surgery, a core stability exercise program will be initiated. The patient will attend the physiotherapy center twice weekly for 6 weeks. The core stability program will consist of 15 minutes of exercises designed to strengthen the abdominal, back, and gluteal muscles. Intervention 2: Control group: The patient will attend the physiotherapy center 24 hours after surgery and will continue treatment for 6 weeks. During this period, the patient will attend the physiotherapy center three times per week. The treatment program will include 15 minutes of Transcutaneous Electrical Nerve Stimulation (TENS), 15 minutes of Interferential Therapy (IFT), hip strengthening exercises, range of motion exercises, gait training, and functional exercises (2 sets of 10 repetitions). If the patient experiences lower-limb muscle spasms, dry needling or the Graston technique will be applied as appropriate.After the initial 6-week period, the patient will attend the physiotherapy center twice weekly for an additional 6 weeks and will continue performing the same exercise program described above.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The results of the treatment will be published without mentioning the names of the participants.

When:
It is expected that the data will be published approximately 6 months after sampling and treatment.

To whom:
All individuals who need it.

Conditions:
The data will be used to evaluate the effect of the intervention performed.

Where to obtain:
Project contact person / Project coordinator

How to obtain:
Via phone call and email.

Comments:
none</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Mallaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>"Unit 1 (West), No. 9, Tolou 3 St., Kouhak Blvd., Chitgar, Tehran, Iran"</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1485713616</zip>
        <telephone>+98 21 4608 9765</telephone>
        <email>yaghobsalmani1357@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mohsen Abedi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran, Imam Hossein Square, Damavand Street (Tehran Pars area), opposite , School of Rehabilitation Sciences, .</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1616913111</zip>
        <telephone>00982177561721-242</telephone>
        <email>mohsenabedi110@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>unilateral total hip arthroplasty due to developmental hip dislocation.
age range between 18 and 60 years.
cementless total hip replacement using the subtrochanteric shortening osteotomy (digastric technique).
absence of postoperative complications (such as infection, fracture, nerve injury, etc.).
no history of other underlying conditions (e.g., discopathy, multiple sclerosis, advanced osteoarthritis of other joints, etc.).
primary (first-time) total hip arthroplasty.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>total hip replacement due to other causes (such as advanced hip osteoarthritis, avascular necrosis of the femoral head, etc.).
partial joint replacement.
cemented or other surgical techniques.
presence of surgical complications.
presence of other underlying medical conditions.
revision surgery (second or subsequent joint replacement).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The patient will attend the physiotherapy center 24 hours after surgery and will continue treatment for 6 weeks. During this period, the patient will attend the physiotherapy center three times per week. The treatment program will include 15 minutes of Transcutaneous Electrical Nerve Stimulation (TENS), 15 minutes of Interferential Therapy (IFT), hip strengthening exercises, range of motion exercises, gait training, and functional exercises (2 sets of 10 repetitions). If the patient develops lower-limb muscle spasms, dry needling or the Graston technique will be used as appropriate.Six weeks after surgery, a core stability exercise program will be initiated. The patient will attend the physiotherapy center twice weekly for 6 weeks. The core stability program will consist of 15 minutes of exercises designed to strengthen the abdominal, back, and gluteal muscles.</i_keyword>
      <i_keyword>Control group: The patient will attend the physiotherapy center 24 hours after surgery and will continue treatment for 6 weeks. During this period, the patient will attend the physiotherapy center three times per week. The treatment program will include 15 minutes of Transcutaneous Electrical Nerve Stimulation (TENS), 15 minutes of Interferential Therapy (IFT), hip strengthening exercises, range of motion exercises, gait training, and functional exercises (2 sets of 10 repetitions). If the patient experiences lower-limb muscle spasms, dry needling or the Graston technique will be applied as appropriate.After the initial 6-week period, the patient will attend the physiotherapy center twice weekly for an additional 6 weeks and will continue performing the same exercise program described above.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Quality of life. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: HOOS questionnaire.</prim_outcome>
      <prim_outcome>Physical function. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: TUG test.</prim_outcome>
      <prim_outcome>Core stability. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: Force plate.</prim_outcome>
      <prim_outcome>Number of sit-to-stand tests. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: sit-to-stand tests.</prim_outcome>
      <prim_outcome>Duration of standing on the operated leg. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: single leg stand test.</prim_outcome>
      <prim_outcome>Center of pressure (COP) velocity. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: Force plate.</prim_outcome>
      <prim_outcome>Center of pressure (COP) displacement. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: Force plate.</prim_outcome>
      <prim_outcome>Side effects. Timepoint: Individuals before starting core stability exercises (6 weeks after surgery), 6 weeks after starting core stability exercises (12 weeks after surgery), and 6 months after surgery. Method of measurement: The participant will be interviewed using a structured questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>none</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-08-17</approval_date>
        <contact_name>"Deputy of Research and Technology, Shahid Beheshti University of Medical Sciences (Research Ethics </contact_name>
        <contact_address>"Unit 1 (West), No. 9, Tolou 3 St., Kouhak Blvd., Chitgar, Tehran, Iran" tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
